Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 14.10.19981 Min. Lesezeit
Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring; Extension of Comment Period
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is extending to November 16, 1998, the comment period on a proposed rule that was published in the Federal Register of May 22, 1998 (63 FR 28301). The document proposed to amend the drug and biologics regulations by adding provisions that would clarify the evaluation and approval of in vivo radiopharmaceuticals used for diagnosis and monitoring. The agency is taking this action to provide interested persons additional time to submit comments to FDA on the proposed rule.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →